Pain

Healio has launched a new special report on medical cannabis that summarizes the current scientific research and incorporates expert opinion.

Surgeons at Northwestern Medicine have performed the first kidney transplant in the U.S. in which the patient was awake during procedure, according to a press release from the hospital.

SAN DIEGO — Treating migraine with a novel formulation of dihydroergotamine powder was linked to favorable outcomes including significant headache pain reduction at 48 hours post dose that was extended to 12 months.

SAN DIEGO — A wearable remote electrical neuromodulation device provided consistent efficacy and clinically meaningful benefit to those with migraine, according to a poster presentation at the American Headache Society Annual Scientific Meeting.

SAN DIEGO — AI-based models are currently best utilized as a predictor of headache, but show promise for expansion into the health care continuum, according to a speaker at the American Headache Society Annual Scientific Meeting.

Adults with hypoparathyroidism experience declines in cognitive function that may be due to structural changes in the brain, according to findings published in the Journal of Bone and Mineral Research.

Vevye, a nonpreserved cyclosporine 0.1% ophthalmic solution, demonstrated sustained safety and efficacy among patients with dry eye disease, according to 52-week ESSENCE-2 open-label extension study results published in Cornea.

Self-administered acupressure, combined with a short education program, was a cost-effective method of pain relief that boosted mobility in adults with probable knee osteoarthritis, according to data published in JAMA Network Open.

For readers of my column over the past decade, many will recognize that on numerous occasions I have chosen to discuss empathy.

A considerable proportion of rheumatology patients may have a history of abuse, trauma or post-traumatic stress that contributes an emotional component to their physical pain.